biopharmatips

The Challenges in Analytical Method Development and Validation Manufacturing biologics is not an easy task as drug companies face several challenges while safeguarding patient safety and product quality. Analytical testing offers the data required to produce effective and safe drugs. The growth and validation of analytical methods is key to drug development. The biopharma industry has successfully reduced risk by adopting analytical platform technologies for monoclonal products, drug conjugates, and new molecules. Several methods such as FDA’s Quality-by-Design (QbD) initiative can have a positive impact on validation and analytical method development because the procedures are identified early in the development process. Challenges Associated with Analytical Method Development and Validation The challenges bio pharma companies face with analytical method development and validation are as follows: Often the timelines for developing a drug are tight. However, suf...

A biopharmaceutical is a medicinal product extracted or manufactured using biological sources. Biologics are often referred to as products manufactured using recombinant DNA technology. Biosimilars, on the other hand, are drugs that have been approved. Biopharmaceutical manufacturing has changed drastically over the last few decades.       Major changes have been witnessed in single-use technology whose advantages include reduced resources for cleaning and cleaning validation, better flexibility, and faster turnaround between products and batches, resulting in increased speed to market and reduced capital costs.  Biopharmaceutical process development and manufacturing focuses on the development and the practices and process approaches in providing regulated and cost-effective manufacturing of biologics in a timely manner that fulfil their intended use. Good manufacturing practices ensure that manufacturers constantly produce drugs to ...